Search

Your search keyword '"Claudia Jodhinata"' showing total 5 results
Start Over Author "Claudia Jodhinata" Publication Year Range Last 3 years
5 results on '"Claudia Jodhinata"'

1. Factors related to Post Traumatic Stress Symptoms in Indonesian adults during quarantine of the COVID-19 pandemic

Author

Nadya Nathalia Evangelista, Felix Wijovi, Sisilia Orlin, Stella Angelina, Devina Adella Halim, Claudia Jodhinata, Audrey Hamdoyo, Darien Alfa Cipta, Andree Kurniawan, and Nata Pratama Hardjo Lugito

Subjects
ptss, quarantine, covid-19, demographic factors, ies-r score, Public aspects of medicine, RA1-1270
Abstract

Background: COVID-19 is an unprecedented public health event. It started from Wuhan, China, in late December of 2019 and later spread worldwide. During the pandemic, negative impacts on mental health were found in all groups, including adults of their productive age. Objective: This study aimed to search for factors related to Post Traumatic Stress Symptoms (PTSS) during the quarantine due to the COVID-19 pandemic in Indonesia, specifically about the demographic background of respondents and its relation to PTSS. Methods: This study employed a cross-sectional design involving 257 Indonesian adults aged 26-67 years from 26 out of 34 provinces in Indonesia. The questionnaire used in this study consists of demographic questions and an Indonesian version of the Impact of Event Scale-Revised (IESR). The questionnaire was distributed through a link attached to the social media platform from 17 September to 5 October 2020. Data were analyzed using t-test, one-way ANOVA, and multiple linear regression using SPSS 25.0. Results: The data analysis showed a significant relationship between age and mean IES-R score during quarantine time in Indonesia (p-value 0.001). Other demographic factors such as gender, education level, marital status, work from home, income during the pandemic, and pandemic effects to income showed no significant relation to the IES-R score of the respondents. Adults aged 25-44 years old tend to have higher IES-R scores than those aged 45-64 and 65+ years old. Conclusion: Age was related to the IES-R score, while the other five independent variables included in the linear regression analysis were found to be confounders in this study.

Published
2022
Full Text
View/download PDF

2. The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia

Author

Rivaldo Steven Heriyanto, Andree Kurniawan, Felix Wijovi, Devina Adella Halim, Claudia Jodhinata, Elizabeth Marcella, Billy Susanto, Johan Wibowo, Michele Indrawan, Nadia Khoirunnisa Heryadi, Michelle Imanuelly, Jonathan Juniard Anurantha, Timotius Ivan Hariyanto, Chintya Marcellin, Terry Devita Sinaga, Saraswati Anindita Rizki, Novia Sieto, Jeremia Immanuel Siregar, and Nata Pratama Hardjo Lugito

Subjects
COVID-19, antibody titers, Sinovac vaccine, COVID-19 vaccine, Infectious and parasitic diseases, RC109-216
Abstract

Background: Sinovac was the first vaccine used in Indonesia against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data regarding the effects of certain variables such as clinical demographics on antibody levels in individuals vaccinated with Sinovac are scarce. This study aimed to investigate the impact of gender and previous SARS-CoV-2 infection status on neutralizing antibody titers 1, 2, and 3 months after administration of the Sinovac vaccine.Method: A cross-sectional study was conducted from February to May 2021. Data on neutralizing antibody levels, previous SARS-CoV-2 infection status, and gender were retrieved from the monthly quantitative serology evaluation database of Siloam Hospitals Lippo Village, Tangerang, Indonesia. The role of each variable was analyzed using the t-test or Mann-Whitney U test, depending on data distribution.Result: Data from 350 participants were collected for the study. Participants with a history of a positive SARS-CoV-2 RT-PCR test had significantly higher neutralizing antibody titers in the first (144 U/mL, p = 0.036) and second months (144 U/mL, p = 0.005) after vaccination compared with those without a history of positive RT-PCR test. Female participants also had significantly higher neutralizing antibody titers in the first, second, and third months (43 U/mL, 42 U/mL, and 39 U/mL, respectively; p = 0.001, p = 0.002, and p = 0.003, respectively) after vaccination compared to males.Conclusion: COVID-19 survivor status and the female gender were associated with higher neutralizing antibody titers after Sinovac vaccine administration.

Published
2021
Full Text
View/download PDF

3. The role of COVID‐19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical‐year medical students in Indonesia

Author

Terry Devita Sinaga, Novia Lauren Sieto, Saraswati Anindita Rizki, B. Susanto, Johan Wibowo, Michele Indrawan, Felix Wijovi, Jonathan Juniard Anurantha, Jeremia Immanuel Siregar, Devina Adella Halim, Michelle Imanuelly, Andree Kurniawan, Claudia Jodhinata, Nadia Khoirunnisa Heryadi, Timotius Ivan Hariyanto, Nata Pratama Hardjo Lugito, E. Marcella, R.S. Heriyanto, and Chintya Marcellin

Subjects
Microbiology (medical), Male, medicine.medical_specialty, Students, Medical, Coronavirus disease 2019 (COVID-19), Infectious and parasitic diseases, RC109-216, Antibodies, Viral, Article, Serology, Vaccine administration, Internal medicine, Medicine, Humans, Survivors, Neutralizing antibody, Vaccines, biology, business.industry, SARS-CoV-2, Vaccination, Antibody titer, COVID-19, General Medicine, Antibodies, Neutralizing, Sinovac vaccine, Titer, Infectious Diseases, Cross-Sectional Studies, Indonesia, Mann–Whitney U test, biology.protein, Female, antibody titers, business, COVID-19 vaccine
Abstract

Background: Sinovac was the first vaccine used in Indonesia against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, data regarding the effects of certain variables such as clinical demographics on antibody levels in individuals vaccinated with Sinovac are scarce. This study aimed to investigate the impact of gender and previous SARS-CoV-2 infection status on neutralizing antibody titers 1, 2, and 3 months after administration of the Sinovac vaccine.Method: A cross-sectional study was conducted from February to May 2021. Data on neutralizing antibody levels, previous SARS-CoV-2 infection status, and gender were retrieved from the monthly quantitative serology evaluation database of Siloam Hospitals Lippo Village, Tangerang, Indonesia. The role of each variable was analyzed using the t-test or Mann-Whitney U test, depending on data distribution.Result: Data from 350 participants were collected for the study. Participants with a history of a positive SARS-CoV-2 RT-PCR test had significantly higher neutralizing antibody titers in the first (144 U/mL, p = 0.036) and second months (144 U/mL, p = 0.005) after vaccination compared with those without a history of positive RT-PCR test. Female participants also had significantly higher neutralizing antibody titers in the first, second, and third months (43 U/mL, 42 U/mL, and 39 U/mL, respectively; p = 0.001, p = 0.002, and p = 0.003, respectively) after vaccination compared to males.Conclusion: COVID-19 survivor status and the female gender were associated with higher neutralizing antibody titers after Sinovac vaccine administration.

Published
2021

4. The Determinants of COVID-19 Vaccine Acceptance in Sumatra

Author

Cindy Sidarta, Andree Kurniawan, Nata Pratama Hardjo Lugito, Jeremia Imanuel Siregar, Veli Sungono, Rivaldo Steven Heriyanto, Novia Lauren Sieto, Devina Adella Halim, Claudia Jodhinata, Saraswati Anindita Rizki, Terry Devita Sinaga, Chintya Marcella, Felix Wijovi, Billy Susanto, Elizabeth Marcella, Johan Wibowo, Jonathan Juniard Anurantha, Michelle Imanuelly, Michele Indrawan, and Nadia Khoirunnisa Heryadi

Subjects
Epidemiology, Health Policy, Public Health, Environmental and Occupational Health
Abstract

In light of the current vaccination programs being implemented worldwide, this study aimed to evaluate the determinants of coronavirus disease 2019 (COVID-19) vaccine acceptance in Sumatra, Indonesia. According to a COVID-19 vaccine acceptance survey conducted in Indonesia by the World Health Organization (WHO), the Ministry of Health of the Republic of Indonesia, the National Immunization Technical Advisory Group (NITAG), and the United Nations Children’s Fund (UNICEF), published in November 2020, Sumatra is among the places having lower COVID-19 vaccine acceptance rates, with Aceh Province displaying the lowest level of vaccine acceptance. Thus, a cross-sectional study was conducted, and a logistic regression analysis was used to identify the factors affecting COVID-19 vaccine acceptance. Out of 368 respondents who participated in the survey, 143 (38.9%) accepted the vaccine, and 225 (61.1%) refused it. Vaccine safety concerns constituted the most reported reason for refusal (43.6%). This study also found that province of residence and basic immunization status were determinants of COVID-19 vaccine acceptance in Sumatra. Concerns regarding vaccine safety might be the reason for the low level of vaccination in Sumatra. Increased education and encouragement from healthcare professionals and regional authority figures can alleviate public concerns and improve vaccine acceptance.

Published
2022

5. Psychometric Properties of the Indonesian Version of Impact of Event Scale-Revised Questionnaire During COVID-19 Pandemic

Author

Stella Angelina, Darien Alfa Cipta, Fransisca Handy Agung, Claudia Jodhinata, Andree Kurniawan, Sisilia Orlin, Audrey Hamdoyo, Nata Pratama Hardjo Lugito, Felix Wijovi, Nadya Nathalia Evangelista, and Devina Adella Halim

Subjects
medicine.medical_specialty, education.field_of_study, Population, General Engineering, Respiratory infection, Validity, language.human_language, Pearson product-moment correlation coefficient, Indonesian, symbols.namesake, Cronbach's alpha, Epidemiology, Pandemic, medicine, language, symbols, Psychology, education, Clinical psychology
Abstract

Background: COVID-19 is a respiratory infection caused by SARS CoV-2. A health-related disaster may result in a wide range of mental consequences, including PTSD. IES-R is a self-reported instrument, and it corresponds to DSM-IV symptoms of PTSD. However, there were scarce data about the validation of the Indonesian version of IESR.Aim: The purpose of this study was to validate the IES-R in the Indonesian adult population by comprehensively and systematically assessing the epidemiological evidence about PTSS during the COVID-19 pandemic.Methods: This was a cross-sectional study. The IES-R questionnaire was translated from English to Indonesian, back-translated. All health workers were excluded to avoid the biased result. Pearson correlation and Cronbach's alpha coefficients to determine the validity and reliability of the questionnaire.Results: A total of 234 Indonesian-speaking adults completed the survey. The Indonesian IES-R had proven to be a valid (r= 0.756 -0.938, p= 0.000) and reliable (alpha coefficient: 0.858-0.868) measure for PTSS in a sample of Indonesian adults during the COVID-19 pandemic. In addition, the final model which consisted of 3 subscales with 20 items demonstrated acceptable factor loadings.Conclusion: The results of this study suggested IESR is valid and reliable to be used in the Indonesian population especially during pandemics.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results